BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $591 | -12.6% | 15,550 | +5.4% | 0.29% | -7.7% |
| Q2 2023 | $676 | -6.6% | 14,750 | -16.9% | 0.31% | -14.1% |
| Q1 2023 | $724 | +10.7% | 17,750 | +39.2% | 0.36% | +0.3% |
| Q4 2022 | $654 | -99.9% | 12,750 | 0.0% | 0.36% | -9.1% |
| Q3 2022 | $690,000 | -16.2% | 12,750 | 0.0% | 0.40% | -12.0% |
| Q2 2022 | $823,000 | +36.5% | 12,750 | +64.5% | 0.45% | +63.6% |
| Q1 2022 | $603,000 | -9.6% | 7,750 | 0.0% | 0.28% | -1.4% |
| Q4 2021 | $667,000 | +6.5% | 7,750 | 0.0% | 0.28% | -4.8% |
| Q3 2021 | $626,000 | 0.0% | 7,750 | 0.0% | 0.29% | +3.9% |
| Q2 2021 | $626,000 | -5.2% | 7,750 | -0.6% | 0.28% | -12.4% |
| Q1 2021 | $660,000 | +5.1% | 7,800 | 0.0% | 0.32% | +1.6% |
| Q4 2020 | $628,000 | -0.2% | 7,800 | 0.0% | 0.32% | -9.7% |
| Q3 2020 | $629,000 | -6.5% | 7,800 | 0.0% | 0.35% | -19.5% |
| Q2 2020 | $673,000 | +6.0% | 7,800 | 0.0% | 0.44% | -14.5% |
| Q1 2020 | $635,000 | -2.9% | 7,800 | 0.0% | 0.51% | +19.2% |
| Q4 2019 | $654,000 | -4.4% | 7,800 | 0.0% | 0.43% | -13.4% |
| Q3 2019 | $684,000 | +6.9% | 7,800 | 0.0% | 0.49% | +4.9% |
| Q2 2019 | $640,000 | +0.8% | 7,800 | 0.0% | 0.47% | +1.1% |
| Q1 2019 | $635,000 | +23.3% | 7,800 | 0.0% | 0.47% | +9.6% |
| Q4 2018 | $515,000 | -14.6% | 7,800 | 0.0% | 0.42% | +2.7% |
| Q3 2018 | $603,000 | +4.5% | 7,800 | 0.0% | 0.41% | -4.2% |
| Q2 2018 | $577,000 | -99.9% | 7,800 | 0.0% | 0.43% | +11.9% |
| Q1 2018 | $508,560,000 | +0.6% | 7,800 | 0.0% | 0.39% | +6.9% |
| Q4 2017 | $505,440,000 | +3.3% | 7,800 | 0.0% | 0.36% | -1.6% |
| Q3 2017 | $489,450,000 | – | 7,800 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 298,721 | $23,969,000 | 8.70% |
| GENERATION INVESTMENT MANAGEMENT LLP | 17,424,560 | $1,398,147,000 | 6.24% |
| Soditic Asset Management LLP | 77,950 | $6,255,000 | 6.24% |
| Veritas Asset Management LLP | 11,110,132 | $891,477,000 | 5.32% |
| Dash Acquisitions Inc. | 84,560 | $6,785,000 | 4.74% |
| Prosight Management, LP | 121,075 | $9,715,000 | 4.49% |
| TSFG, LLC | 94,977 | $7,621,000 | 4.07% |
| CINCINNATI FINANCIAL CORP | 1,344,648 | $107,895,000 | 2.93% |
| Dundas Partners LLP | 204,535 | $19,304,000 | 2.82% |
| Unified Trust Company, N.A. | 59,491 | $4,689,000 | 2.72% |